CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -34.8% | 13,000 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $23,000 | -11.5% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | -25.7% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -39.7% | 13,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $58,000 | -22.7% | 13,000 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $75,000 | -17.6% | 13,000 | 0.0% | 0.01% | -23.1% |
| Q1 2021 | $91,000 | +46.8% | 13,000 | 0.0% | 0.01% | +30.0% |
| Q4 2020 | $62,000 | -18.4% | 13,000 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $76,000 | -13.6% | 13,000 | 0.0% | 0.01% | -17.6% |
| Q2 2020 | $88,000 | +6.0% | 13,000 | 0.0% | 0.02% | -10.5% |
| Q1 2020 | $83,000 | -39.0% | 13,000 | 0.0% | 0.02% | -17.4% |
| Q4 2019 | $136,000 | +166.7% | 13,000 | 0.0% | 0.02% | +155.6% |
| Q3 2019 | $51,000 | -73.6% | 13,000 | 0.0% | 0.01% | -74.3% |
| Q2 2019 | $193,000 | -40.2% | 13,000 | 0.0% | 0.04% | -40.7% |
| Q1 2019 | $323,000 | +28.7% | 13,000 | -7.1% | 0.06% | +13.5% |
| Q4 2018 | $251,000 | -38.9% | 14,000 | 0.0% | 0.05% | -25.7% |
| Q3 2018 | $411,000 | -30.5% | 14,000 | +7.7% | 0.07% | -34.0% |
| Q2 2018 | $591,000 | +1.7% | 13,000 | +18.2% | 0.11% | +1.9% |
| Q1 2018 | $581,000 | -5.1% | 11,000 | +22.2% | 0.10% | -1.9% |
| Q4 2017 | $612,000 | -17.5% | 9,000 | 0.0% | 0.11% | -21.5% |
| Q3 2017 | $742,000 | – | 9,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |